CARNITOR INJECTION Rx
Generic Name and Formulations:
Levocarnitine 200mg/mL; soln for IV bolus inj or infusion; preservative-free.
Sigma-Tau Pharmaceuticals, Inc.
Indications for CARNITOR INJECTION:
Secondary carnitine deficiency. Carnitine deficiency in end stage renal disease (ESRD) patients undergoing dialysis.
Adults and Children:
Secondary carnitine deficiency: 50mg/kg IV as slow (2–3 minutes) bolus inj or by infusion; usual max 300mg/kg. May give loading dose in severe metabolic crisis: see literature. ESRD: initially 10–20mg/kg dry body weight as slow (2–3 minutes) IV bolus inj into venous return line after each dialysis session; adjust dose based on trough levocarnitine levels.
Obtain baseline carnitine level; monitor blood chemistry, carnitine levels, vital signs, clinical condition. Seizure disorders. Renal insufficiency (oral forms). Pregnancy (Cat.B). Nursing mothers: not recommended.
Concomitant warfarin: monitor INR.
GI upset/pain, body odor, seizures; inj: hypercalcemia, local reactions.
Tabs—90; Oral soln—4oz; Inj amps or vials (single-dose 5mL)—5
Neurology Advisor Articles
- The Consequences of Compensation in Autism
- Fingolimod May Help Prevent Brain Volume Loss in Relapsing-Remitting Multiple Sclerosis
- Novel Therapy May Improve Symptoms in Early Huntington Disease
- Interaction of Alcohol, Smoking on Multiple Sclerosis Severity
- Demoralization Common in Patients With Parkinson Disease
- Multiple Sclerosis Guidelines: AAN's Recommendations for Initiating, Switching, Stopping Disease-Modifying Therapy
- Migraine a Common Comorbidity in Individuals With Sarcoidosis
- Cardiovascular Risk Factors and Development of Brain Atrophy in Multiple Sclerosis
- Association Between Multiple Sclerosis Relapses and Vaccinations
- Understanding Impulse Control Disorders in Parkinson Disease: Developments and Treatments